Comparative Antiresorptive Efficacy Discontinuation of Denosumab
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 50
Summary
- Conditions
- Osteoporosis
- Osteoporosis, Postmenopausal
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Single (Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 45 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03623633
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Joy Tsai, MD MGH